Annual CFO
-$192.98 M
+$77.45 M+28.64%
31 December 2023
Summary:
Atara Biotherapeutics annual cash flow from operations is currently -$192.98 million, with the most recent change of +$77.45 million (+28.64%) on 31 December 2023. During the last 3 years, it has fallen by -$12.22 million (-6.76%). ATRA annual CFO is now -3134.61% below its all-time high of -$5.97 million, reached on 31 December 2013.ATRA Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$3.99 M
+$6.66 M+62.53%
30 September 2024
Summary:
Atara Biotherapeutics quarterly cash flow from operations is currently -$3.99 million, with the most recent change of +$6.66 million (+62.53%) on 30 September 2024. Over the past year, it has increased by +$47.36 million (+92.23%). ATRA quarterly CFO is now -453.32% below its all-time high of $1.13 million, reached on 30 June 2013.ATRA Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$94.65 M
+$47.36 M+33.35%
30 September 2024
Summary:
Atara Biotherapeutics TTM cash flow from operations is currently -$94.65 million, with the most recent change of +$47.36 million (+33.35%) on 30 September 2024. Over the past year, it has increased by +$104.80 million (+52.54%). ATRA TTM CFO is now -5193.74% below its all-time high of -$1.79 million, reached on 30 June 2013.ATRA TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ATRA Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +28.6% | +92.2% | +52.5% |
| 3 y3 years | -6.8% | +93.2% | +50.3% |
| 5 y5 years | -7.3% | +92.3% | +59.6% |
ATRA Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -6.8% | +28.6% | at high | +95.3% | at high | +65.0% |
| 5 y | 5 years | -7.3% | +28.6% | at high | +95.3% | at high | +65.0% |
| alltime | all time | -3134.6% | +28.6% | -453.3% | +95.3% | -5193.7% | +65.0% |
Atara Biotherapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$3.99 M(-62.5%) | -$94.65 M(-33.3%) |
| June 2024 | - | -$10.64 M(-64.1%) | -$142.01 M(-22.9%) |
| Mar 2024 | - | -$29.61 M(-41.3%) | -$184.16 M(-4.6%) |
| Dec 2023 | -$192.98 M(-28.6%) | -$50.41 M(-1.8%) | -$192.98 M(-3.2%) |
| Sept 2023 | - | -$51.35 M(-2.7%) | -$199.45 M(-6.4%) |
| June 2023 | - | -$52.80 M(+37.4%) | -$213.16 M(-5.0%) |
| Mar 2023 | - | -$38.43 M(-32.4%) | -$224.33 M(-17.0%) |
| Dec 2022 | -$270.43 M(+22.6%) | -$56.88 M(-12.6%) | -$270.43 M(+9.1%) |
| Sept 2022 | - | -$65.06 M(+1.7%) | -$247.82 M(+2.5%) |
| June 2022 | - | -$63.96 M(-24.3%) | -$241.74 M(+1.0%) |
| Mar 2022 | - | -$84.53 M(+146.7%) | -$239.35 M(+8.5%) |
| Dec 2021 | -$220.52 M(+22.0%) | -$34.27 M(-41.9%) | -$220.52 M(+15.8%) |
| Sept 2021 | - | -$58.98 M(-4.2%) | -$190.37 M(+3.3%) |
| June 2021 | - | -$61.58 M(-6.3%) | -$184.35 M(+2.8%) |
| Mar 2021 | - | -$65.70 M(+1494.6%) | -$179.41 M(-0.7%) |
| Dec 2020 | -$180.76 M(-23.3%) | -$4.12 M(-92.2%) | -$180.76 M(-23.2%) |
| Sept 2020 | - | -$52.96 M(-6.5%) | -$235.33 M(+0.3%) |
| June 2020 | - | -$56.64 M(-15.5%) | -$234.52 M(+0.9%) |
| Mar 2020 | - | -$67.04 M(+14.2%) | -$232.47 M(-1.3%) |
| Dec 2019 | -$235.63 M(+31.1%) | -$58.69 M(+12.5%) | -$235.63 M(+0.5%) |
| Sept 2019 | - | -$52.15 M(-4.5%) | -$234.35 M(+1.8%) |
| June 2019 | - | -$54.59 M(-22.2%) | -$230.31 M(+7.0%) |
| Mar 2019 | - | -$70.20 M(+22.3%) | -$215.15 M(+19.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$179.77 M(+105.4%) | -$57.42 M(+19.4%) | -$179.77 M(+22.1%) |
| Sept 2018 | - | -$48.10 M(+22.0%) | -$147.29 M(+23.3%) |
| June 2018 | - | -$39.43 M(+13.2%) | -$119.42 M(+19.1%) |
| Mar 2018 | - | -$34.82 M(+39.6%) | -$100.29 M(+14.6%) |
| Dec 2017 | -$87.50 M(+45.8%) | -$24.94 M(+23.3%) | -$87.50 M(+4.5%) |
| Sept 2017 | - | -$20.23 M(-0.4%) | -$83.73 M(+5.9%) |
| June 2017 | - | -$20.30 M(-7.9%) | -$79.08 M(+13.7%) |
| Mar 2017 | - | -$22.03 M(+4.1%) | -$69.57 M(+15.9%) |
| Dec 2016 | -$60.02 M(+61.5%) | -$21.16 M(+35.8%) | -$60.02 M(+19.4%) |
| Sept 2016 | - | -$15.58 M(+44.4%) | -$50.25 M(+5.6%) |
| June 2016 | - | -$10.79 M(-13.6%) | -$47.57 M(+10.6%) |
| Mar 2016 | - | -$12.49 M(+9.6%) | -$43.02 M(+15.8%) |
| Dec 2015 | -$37.16 M(+123.5%) | -$11.39 M(-11.7%) | -$37.16 M(+20.9%) |
| Sept 2015 | - | -$12.90 M(+106.7%) | -$30.72 M(+40.2%) |
| June 2015 | - | -$6.24 M(-5.7%) | -$21.91 M(+7.8%) |
| Mar 2015 | - | -$6.62 M(+33.6%) | -$20.33 M(+22.3%) |
| Dec 2014 | -$16.63 M(+178.7%) | -$4.96 M(+21.1%) | -$16.63 M(+17.4%) |
| Sept 2014 | - | -$4.09 M(-12.2%) | -$14.16 M(+20.4%) |
| June 2014 | - | -$4.66 M(+59.8%) | -$11.76 M(+97.1%) |
| Mar 2014 | - | -$2.92 M(+17.2%) | -$5.97 M(0.0%) |
| Dec 2013 | -$5.97 M | -$2.49 M(+47.4%) | -$5.97 M(+71.6%) |
| Sept 2013 | - | -$1.69 M(-249.6%) | -$3.48 M(+94.5%) |
| June 2013 | - | $1.13 M(-138.7%) | -$1.79 M(-38.7%) |
| Mar 2013 | - | -$2.92 M | -$2.92 M |
FAQ
- What is Atara Biotherapeutics annual cash flow from operations?
- What is the all time high annual CFO for Atara Biotherapeutics?
- What is Atara Biotherapeutics annual CFO year-on-year change?
- What is Atara Biotherapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Atara Biotherapeutics?
- What is Atara Biotherapeutics quarterly CFO year-on-year change?
- What is Atara Biotherapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Atara Biotherapeutics?
- What is Atara Biotherapeutics TTM CFO year-on-year change?
What is Atara Biotherapeutics annual cash flow from operations?
The current annual CFO of ATRA is -$192.98 M
What is the all time high annual CFO for Atara Biotherapeutics?
Atara Biotherapeutics all-time high annual cash flow from operations is -$5.97 M
What is Atara Biotherapeutics annual CFO year-on-year change?
Over the past year, ATRA annual cash flow from operations has changed by +$77.45 M (+28.64%)
What is Atara Biotherapeutics quarterly cash flow from operations?
The current quarterly CFO of ATRA is -$3.99 M
What is the all time high quarterly CFO for Atara Biotherapeutics?
Atara Biotherapeutics all-time high quarterly cash flow from operations is $1.13 M
What is Atara Biotherapeutics quarterly CFO year-on-year change?
Over the past year, ATRA quarterly cash flow from operations has changed by +$47.36 M (+92.23%)
What is Atara Biotherapeutics TTM cash flow from operations?
The current TTM CFO of ATRA is -$94.65 M
What is the all time high TTM CFO for Atara Biotherapeutics?
Atara Biotherapeutics all-time high TTM cash flow from operations is -$1.79 M
What is Atara Biotherapeutics TTM CFO year-on-year change?
Over the past year, ATRA TTM cash flow from operations has changed by +$104.80 M (+52.54%)